1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA INSIG2 CTRPv2 pan-cancer AAC 0.093 0.02
mRNA SYTL2 CTRPv2 pan-cancer AAC 0.096 0.02
mRNA DNAL1 CTRPv2 pan-cancer AAC -0.096 0.02
mRNA FAM72B CTRPv2 pan-cancer AAC -0.11 0.02
mRNA BAMBI CTRPv2 pan-cancer AAC 0.097 0.02
mRNA GPATCH4 CTRPv2 pan-cancer AAC -0.092 0.02
mRNA COL1A2 CTRPv2 pan-cancer AAC -0.095 0.02
mRNA ZNF510 CTRPv2 pan-cancer AAC -0.093 0.02
mRNA NUMBL CTRPv2 pan-cancer AAC -0.096 0.02
mRNA ADRA1A CTRPv2 pan-cancer AAC 0.089 0.02
Download CSV